Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02576574
Title Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors EMD Serono
Indications

lung non-small cell carcinoma

Therapies

Gemcitabine

Paclitaxel

Cisplatin

Avelumab

Pemetrexed Disodium

Carboplatin

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST